Literature DB >> 32075073

An Innovative Public-Private Mix Model for Improving Tuberculosis Care in Vietnam: How Well are We Doing?

Thuong Do Thu1, Ajay M V Kumar2,3,4, Gomathi Ramaswamy5, Thurain Htun6, Hoi Le Van1, Luan Vo Nguyen Quang7, Thuy Dong Thi Thu7, Andrew Codlin7, Rachel Forse7, Jacob Crewsell8, Hoi Nguyen Thanh9, Hai Nguyen Viet1, Huy Bui Van1, Hoa Nguyen Binh1,3,10, Nhung Nguyen Viet1,10.   

Abstract

To improve tuberculosis (TB) care among individuals attending a private tertiary care hospital in Vietnam, an innovative private sector engagement model was implemented from June to December 2018. This included: (i) Active facility-based screening of all adults for TB symptoms (and chest x-ray (CXR) for those with symptoms) by trained and incentivized providers, with on-site diagnostic testing or transport of sputum samples, (ii) a mobile application to reduce dropout in the care cascade and (iii) enhanced follow-up care by community health workers. We conducted a cohort study using project and routine surveillance data for evaluation. Among 52,078 attendees, 368 (0.7%) had symptoms suggestive of TB and abnormalities on CXR. Among them, 299 (81%) were tested and 103 (34.4%) were diagnosed with TB. In addition, 195 individuals with normal CXR were indicated for TB testing by attending clinicians, of whom, seven were diagnosed with TB. Of the 110 TB patients diagnosed, 104 (95%) were initiated on treatment and 97 (93%) had a successful treatment outcome. Given the success of this model, the National TB Programme is considering to scale it up nationwide after undertaking a detailed cost-effectiveness analysis.

Entities:  

Keywords:  SORT IT; missing cases; operational research; public–private mix model; public–private partnership

Year:  2020        PMID: 32075073     DOI: 10.3390/tropicalmed5010026

Source DB:  PubMed          Journal:  Trop Med Infect Dis        ISSN: 2414-6366


  6 in total

1.  Number needed to screen for TB in clinical, structural or occupational risk groups.

Authors:  F Naufal; L H Chaisson; K O Robsky; P Delgado-Barroso; H S Alvarez-Manzo; C R Miller; A E Shapiro; J E Golub
Journal:  Int J Tuberc Lung Dis       Date:  2022-06-01       Impact factor: 3.427

Review 2.  A review of mobile health interventions for public private mix in tuberculosis care.

Authors:  Wilson Tumuhimbise; Angella Musiimenta
Journal:  Internet Interv       Date:  2021-06-16

3.  The feasibility of a public-private mix program on pulmonary tuberculosis screening in Penang: A pilot study.

Authors:  Wei Shuong Tang; Mei Wai Chan; Fei Ping Kow; Ranjini Ambigapathy; Justen Han Wei Wong; Vasantha Thiruvengadam; Umarazina Abd Kadir; Anita Jain; Ramesvari Pararajasingam Pillai
Journal:  Malays Fam Physician       Date:  2021-01-31

4.  Optimizing Active Tuberculosis Case Finding: Evaluating the Impact of Community Referral for Chest X-ray Screening and Xpert Testing on Case Notifications in Two Cities in Viet Nam.

Authors:  Tuan Huy Mac; Thuc Huy Phan; Van Van Nguyen; Thuy Thu Thi Dong; Hoi Van Le; Quan Duc Nguyen; Tho Duc Nguyen; Andrew James Codlin; Thuy Doan To Mai; Rachel Jeanette Forse; Lan Phuong Nguyen; Tuan Ho Thanh Luu; Hoa Binh Nguyen; Nhung Viet Nguyen; Xanh Thu Pham; Phap Ngoc Tran; Amera Khan; Luan Nguyen Quang Vo; Jacob Creswell
Journal:  Trop Med Infect Dis       Date:  2020-11-30

Review 5.  Hospital services under public-private partnerships, outcomes and, challenges: A literature review.

Authors:  Masyitoh Basabih; Eko Prasojo; Amy Yayuk Sri Rahayu
Journal:  J Public Health Res       Date:  2022-08-26

6.  A comparative impact evaluation of two human resource models for community-based active tuberculosis case finding in Ho Chi Minh City, Viet Nam.

Authors:  Luan Nguyen Quang Vo; Rachel Jeanette Forse; Andrew James Codlin; Thanh Nguyen Vu; Giang Truong Le; Giang Chau Do; Vinh Van Truong; Ha Minh Dang; Lan Huu Nguyen; Hoa Binh Nguyen; Nhung Viet Nguyen; Jens Levy; Bertie Squire; Knut Lonnroth; Maxine Caws
Journal:  BMC Public Health       Date:  2020-06-15       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.